CD8A and neoplasm: Wang et al. generated a monoclonal antibody specifically targeting Siglec-15 (α-S15, clone 5G12), which promoted CD8+ T-cells’ proliferation and suppressed tumor growth in mice, indicating that mAb acting against Siglec-15 has great therapeutic potential for immunotherapy [94].